{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:25:05Z","timestamp":1790411105961,"version":"4.1.0"},"reference-count":29,"publisher":"European Respiratory Society (ERS)","issue":"2","content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2017,12,4]]},"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1183\/13993003.02497-2017","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T01:50:22Z","timestamp":1517449822000},"page":"1702497","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["<i>Pseudomonas aeruginosa<\/i>infection and exacerbations in bronchiectasis: more questions than answers"],"prefix":"10.1183","volume":"51","author":[{"given":"Miguel Angel","family":"Martinez-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2018,1,31]]},"reference":[{"key":"2024101909315236000_51.2.1702497.1","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S2213-2600(16)30320-4","article-title":"Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study","volume":"4","author":"McDonnell","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2024101909315236000_51.2.1702497.2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.97.10081754"},{"key":"2024101909315236000_51.2.1702497.3","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-0490"},{"key":"2024101909315236000_51.2.1702497.4","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201203-0487OC"},{"key":"2024101909315236000_51.2.1702497.5","doi-asserted-by":"publisher","DOI":"10.1177\/1479972316643698"},{"key":"2024101909315236000_51.2.1702497.6","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00003709"},{"key":"2024101909315236000_51.2.1702497.7","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201506-333OC"},{"key":"2024101909315236000_51.2.1702497.8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201309-1575OC"},{"key":"2024101909315236000_51.2.1702497.9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2147\/COPD.S121943","article-title":"Predicting high risk of exacerbations in bronchiectasis: The E-FACED score","volume":"18","author":"Martinez-Garcia","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dise"},{"key":"2024101909315236000_51.2.1702497.10","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00026313"},{"key":"2024101909315236000_51.2.1702497.11","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01899-2015"},{"key":"2024101909315236000_51.2.1702497.12","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1513\/AnnalsATS.201510-678OC","article-title":"The multiple faces of non-cystic fibrosis bronchiectasis. A cluster analysis approach","volume":"13","author":"Martinez-Garcia","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2024101909315236000_51.2.1702497.13","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1517\/14656566.2015.1019863","article-title":"Challenges in the development of new therapies for bronchiectasis","volume":"16","author":"Chalmers","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"2024101909315236000_51.2.1702497.14","doi-asserted-by":"publisher","DOI":"10.4103\/0974-777X.150885"},{"key":"2024101909315236000_51.2.1702497.15","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01953-2017"},{"key":"2024101909315236000_51.2.1702497.16","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00629-2017"},{"key":"2024101909315236000_51.2.1702497.17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.rmed.2016.06.007","article-title":"Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","volume":"117","author":"Wilson","year":"2016","journal-title":"Respir Med"},{"key":"2024101909315236000_51.2.1702497.18","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201005-0756OC"},{"key":"2024101909315236000_51.2.1702497.19","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201312-2208OC"},{"key":"2024101909315236000_51.2.1702497.20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cct.2017.05.007","article-title":"The RESPIRE trials: Two phase III, randomized, multicentre, placebo-controlled trials of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in non-cystic fibrosis bronchiectasis","volume":"58","author":"Aksamit","year":"2017","journal-title":"Contemp Clin Trials"},{"key":"2024101909315236000_51.2.1702497.21","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2013-203207"},{"key":"2024101909315236000_51.2.1702497.22","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.96.09081601"},{"key":"2024101909315236000_51.2.1702497.23","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00074605"},{"key":"2024101909315236000_51.2.1702497.24","doi-asserted-by":"crossref","unstructured":"Martinez-Garcia MA , M\u00e1iz L , Olveira C , et\u00a0al. Spanish guidelines on treatment of bronchiectasis in adults. Arch Bronconeumol 2017; in press [https:\/\/doi.org\/10.1016\/j.arbres.2017.07.016].","DOI":"10.1016\/j.arbres.2017.07.016"},{"key":"2024101909315236000_51.2.1702497.25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12890-017-0417-3","article-title":"Latin America validation of FACED score in patients with bronchiectasis: an analysis of six cohorts","volume":"17","author":"Athanazio","year":"2017","journal-title":"BMC Pulm Med"},{"key":"2024101909315236000_51.2.1702497.26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1513\/AnnalsATS.201511-740PS","article-title":"Bronchiectasis in China","volume":"13","author":"Lin","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2024101909315236000_51.2.1702497.27","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2012.660480"},{"key":"2024101909315236000_51.2.1702497.28","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00051-2017"},{"key":"2024101909315236000_51.2.1702497.29","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1164\/rccm.201605-1027OC","article-title":"Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis","volume":"195","author":"Chalmers","year":"2017","journal-title":"Am J Respir Crit Care Med"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.02497-2017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:50:04Z","timestamp":1740379804000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.02497-2017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,31]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,1,31]]},"published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1183\/13993003.02497-2017"],"URL":"https:\/\/doi.org\/10.1183\/13993003.02497-2017","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,31]]}}}